Search

Search Constraints

You searched for: Author/Creator Dreussi, Eva

Search Results

1. Clinical validity of a DPYD‐based pharmacogenetic test to predict severe toxicity to fluoropyrimidines. Issue 12 (14th July 2015)

2. Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy. (August 2020)

9. Standard fluoropyrimidine dosages in chemoradiation therapy result in an increased risk of severe toxicity in DPYD variant allele carriers. (November 2018)

10. The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice. Issue 4 (22nd November 2018)